As of my last update in October 2023, GNF-6702, identified by the CAS number 1799329-72-8, is a chemical compound that has been studied primarily for its potential applications in the field of medicinal chemistry, particularly as a selective inhibitor of certain biological pathways. It is characterized by its specific molecular structure, which contributes to its biological activity. GNF-6702 has shown promise in preclinical studies, particularly in the context of targeting specific diseases, although detailed pharmacokinetic and toxicological profiles may still be under investigation. The compound's solubility, stability, and reactivity are important factors that influence its efficacy and safety in therapeutic applications. As with many experimental compounds, ongoing research is essential to fully understand its mechanisms of action, potential side effects, and overall therapeutic potential. For the most accurate and up-to-date information, consulting scientific literature or databases is recommended.

GNF-6702

1799329-72-8: As of my last update in October 2023, GNF-6702, identified by the CAS number 1799329-72-8, is a chemical compound that has been studied primarily for its potential applications in the field of medicinal chemistry, particularly as a selective inhibitor of certain biological pathways. It is characterized by its specific molecular structure, which contributes to its biological activity. GNF-6702 has shown promise in preclinical studies, particularly in the context of targeting specific diseases, although detailed pharmacokinetic and toxicological profiles may still be under investigation. The compound's solubility, stability, and reactivity are important factors that influence its efficacy and safety in therapeutic applications. As with many experimental compounds, ongoing research is essential to fully understand its mechanisms of action, potential side effects, and overall therapeutic potential. For the most accurate and up-to-date information, consulting scientific literature or databases is recommended.

<p>GNF 6703 is a cationic surfactant with potent antimicrobial activity against Leishmania. It also has the ability to disrupt the lipid bilayer of cell membranes and inhibit protein synthesis in susceptible organisms. GNF 6703 is stable at high pH, making it an excellent choice for use in tropical environments where resistant microorganisms are present. The chemical structure of GNF 6703 consists of two nitrogen atoms coordinated by a dinucleotide phosphate, which stabilizes the amide group. This coordination complex is able to bind to ubiquitin-proteasome pathway proteins and disrupt protein synthesis in susceptible organisms.</p>

GNF 6703

<p>GNF6702 inhibits kinetoplastid proteasome, treating leishmaniasis, Chagas, and trypanosomiasis in mice.</p>

CAS 1799329-72-8

GNF-6702

GNF 6703

Ref: 3D-BG180669

GNF6702

Ref: TM-T62362